Genomics in action

Are genetic tests useful to predict cancer?

Genomics plc analysis demonstrates potential for genomic data to identify those most at risk for 16 common diseases

Health secretary wants NHS to roll out genetic tests to detect diseases

Genomics plc analysis featured in Matt Hancock Speech

Polygenic Risk Scores

Genomics plc today announces second close of its Series B financing, raising a further £8 million, bringing the total round to £33 million

Genomics plc contributes to large drug target validation study published in Nature Communications

Genomics plc welcomes paper in Nature journal heralding the ‘power of genetics’ in health research

The UK Biobank resource with deep phenotyping and genomic data

Genomics plc raises £25 million in Series B round to advance its use of human genetics and data science in drug discovery

Vertex and Genomics plc announce multi-year collaboration to use Human Genetics and Data Science to identify novel targets for innovative medicines

Cambridge Office opens

Genomics plc CEO Peter Donnelly on panel at No 10 launch event for UK Life Sciences Sector Deal

Genomics plc teams up with Biogen to discover new drug targets for multiple sclerosis

Innovate UK success story